Clinical Trial Update: Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion (PRAISE) [NA]

View source ↗

Summary

Clinical trial update for RBCs derived from Mirasol-treated whole blood in transfusion-dependent thalassemia; study terminated with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transfusion-dependent Thalassemia

Drugs mentioned

• RBCs Derived From Mirasol-treated Whole Blood

Snippet

Sponsor: Terumo BCTbio | Conditions: Transfusion Dependent Thalassemia | NA | Status: TERMINATED | Results posted: 2021-04-28